In the future, larger scale studies are needed to better clarify and examine the association between HLA I genes, KIR genes and HLA/KIR combinations and NSCLC susceptibility, resistance and disease progression. This evidence concerns the gene KIR3DL1 and non-small cell lung carcinoma.